Proactive Compliance: The Right Prescription for Effective Life Science Data Governance
As if competitive and time-to-market pressures wasn’t enough, IT and compliance professionals in the life sciences field must deal with increased globalization, outsourcing of clinical trials and contract manufacturing, accelerating M&A, a growing volume of costly civil and criminal litigation, and stringent and complicated regulatory environment — all of which require a new approach to data availability and governance.
This recent research by Performance Works identifies current and emerging market needs of biotechnology, pharmaceutical, and medical device companies, as well as key capabilities to manage and govern the growing volume of data beyond the data center.
Download the study to:
- Recognize the most likely data breach scenarios, particularly those that resulted from the sharing of sensitive intellectual property and regulated PII/PHI data.
- Develop effective risk mitigation strategies, and the best ways to safeguard and govern data on end-user devices and third-party cloud applications.
- Learn how companies can play offense by anticipating potential data breaches and violation of data governance policies.